← All diseases
Liver, kidneys and digestion
Liver cirrhosis
Would you like to receive a message when there is new research about Liver cirrhosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Liver cirrhosis is available. View what Premium costs.
Publications and studies (3132)
- Impact of spider nevus and subcutaneous collateral vessel of chest/abdominal wall on outcomes of liver cirrhosis. (2019/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The Dark Side of the Long-Term Use of Proton Pump Inhibitors in Chronic Liver Disease. (2019/03/01) ♡
- Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using Proton Pump Inhibitors. (2019/03/01) ♡
- Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter. (2019/03/01) ♡
- A/H1N1/09 Influenza is Associated With High Mortality in Liver Cirrhosis. (2019/03/01) ♡
- Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography. (2019/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Systems Challenges of Hepatic Carcinomas: A Review. (2019/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Rupture of Hepatocellular Carcinoma: A Review of Literature. (2019/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis. (2019/03/01) ♡
- Derivation and Performance of Standardized Enhanced Liver Fibrosis (ELF) Test Thresholds for the Detection and Prognosis of Liver Fibrosis. (2019/03/01) ♡
- Anti-fibrotic Effects and Mechanism of Shengmai Injection () on Human Hepatic Stellate Cells LX-2. (2019/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. (2019/02/23) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ayurveda Herbal Medicine-induced Liver Cirrhosis. (2019/02/22) ♡
- Effects of poor hepatic reserve in cirrhotic patients with bacterial infections: A population-based study. (2019/02/18) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and safety of umbilical therapy with the traditional Chinese medicine formulation Lishui Xiaogu cataplasm for cirrhotic ascites: protocol for a randomized controlled trial. (2019/02/13) ♡
- Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis. (2019/02/05) ♡
- Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data. (2019/02/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effect of alcohol on the interleukin 6-mediated inflammatory response in a new mouse model of acute-on-chronic liver injury. (2019/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease. (2019/02/01) ♡
- LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis. (2019/02/01) ♡
- Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi. (2019/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Noninvasive diagnosis of nonalcoholic steatohepatitis: Emerging approaches. (2019/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. (2019/02/01) ♡
- HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus Infection. (2019/02/01) ♡
- The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD. (2019/02/01) ♡
- Clinicopathological features of He Shou Wu-induced liver injury: This ancient anti-aging therapy is not liver-friendly. (2019/02/01) ♡
- Chinese herbal medicine reduces acute hepatitis exacerbation in patients with hepatitis B virus infection: A case-control study in Taiwan. (2019/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Effective components of traditional Chinese medicine for regulating TGF-Beta1/Smads signaling pathway in hepatic fibrosis]. (2019/02/01) ♡
- Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-β1. (2019/01/29) ♡
- Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb- Polygonum multiflorum thunb. induced liver injury: a case-control study from a specialised liver disease center in China. (2019/01/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Endoscopic Sedation of the Patient With Cirrhosis. (2019/01/02) ♡
- Influence of resveratrol on liver fibrosis induced by dimethylnitrosamine in male rats. (2019/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Association Between Serum C-Reactive Protein Concentration and Nutritional Status of Malignant Tumor Patients. (2019/01/01) ♡
- Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis. (2019/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies. (2019/01/01) ♡
- Dietary components modulate the risk of hepatocellular carcinoma in cirrhotic patients. (2019/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism. (2019/01/01) ♡
- The Changing Face of Hepatocellular Carcinoma: Forecasting Prevalence of Nonalcoholic Steatohepatitis and Hepatitis C Cirrhosis. (2019/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration. (2019/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis? (2019/01/01) ♡
- Ritonavir-boosted paritaprevir, ombitasvir plus ribavirin could improve eGFR in patients with renal impairment and HCV: an Egyptian cohort. (2019/01/01) ♡
- The Right Liver Lobe Size/Albumin Concentration Ratio in Identifying Esophageal Varices among Patients with Liver Cirrhosis. (2019/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Protective Effect of Ganshuang Granules () on Liver Cirrhosis by Suppressing Regulatory T Cells in Mouse Model. (2019/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The changing epidemiology of liver diseases in the Asia-Pacific region. (2019/01/01) ♡
- Expression of Matrix Metalloproteinase-2, Tissue Inhibitor of Matrix Metalloproteinase-2 and CD147 in the Traditional Chinese Medicine "Compound T11" for Treatment of Chronic Liver Injury. (2019/01/01) ♡
- Alteration of UDP-glucuronosyltransferase 1a1, 1a7 and P-glycoprotein expression in hepatic fibrosis rats and the impact on pharmacokinetics of puerarin. (2019/01/01) ♡
- Efficacy and safety of Yinchen Sini decoction in treating biliary atresia patients after Kasai portoenterostomy: A systematic review and meta-analysis protocol. (2019/01/01) ♡
- CCM111 prevents hepatic fibrosis via cooperative inhibition of TGF-β, Wnt and STAT3 signaling pathways. (2019/01/01) ♡
- Ginger potentiates the effects of silymarin on liver fibrosis induced by CCL4: the role of galectin-8. (2019/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation. (2019/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.